moxifloxacin has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, H; Jang, WH; Kim, B; Kim, KH; Kim, MJ; Kim, WO; Lee, S; Oh, BH; Ryoo, YW | 1 |
| Fabian, I; Halperin, D; Priel, E; Reuveni, D; Shalit, I | 1 |
2 other study(ies) available for moxifloxacin and Carcinoma
| Article | Year |
|---|---|
Moxifloxacin Labeling-Based Multiphoton Microscopy of Skin Cancers in Asians.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Carcinoma; Female; Humans; Male; Microscopy, Fluorescence, Multiphoton; Middle Aged; Moxifloxacin; Skin Neoplasms; Tissue Culture Techniques; Topoisomerase II Inhibitors | 2020 |
Moxifloxacin enhances etoposide-induced cytotoxic, apoptotic and anti-topoisomerase II effects in a human colon carcinoma cell line.
Topics: Antineoplastic Agents; Apoptosis; Aza Compounds; Carcinoma; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Cytotoxins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Enzyme Inhibitors; Etoposide; Fluoroquinolones; HT29 Cells; Humans; Moxifloxacin; Quinolines; Topoisomerase II Inhibitors | 2010 |